Drug
Chlamydia Mrna Vaccine
Chlamydia Mrna Vaccine: highest development phase Phase 1, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Chlamydia mRNA Vaccine NCT06891417 | Phase 1 | Chlamydia Trachomatis Immunization |
Latest
No recent events.
Follow Chlamydia Mrna Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.